These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

483 related articles for article (PubMed ID: 31923639)

  • 1. Fecal Microbiota Transplant Decreases Mortality in Patients with Refractory Severe or Fulminant Clostridioides difficile Infection.
    Cheng YW; Phelps E; Nemes S; Rogers N; Sagi S; Bohm M; El-Halabi M; Allegretti JR; Kassam Z; Xu H; Fischer M
    Clin Gastroenterol Hepatol; 2020 Sep; 18(10):2234-2243.e1. PubMed ID: 31923639
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Systematic Review with Meta-Analysis: Fecal Microbiota Transplantation for Severe or Fulminant Clostridioides difficile.
    Tixier EN; Verheyen E; Luo Y; Grinspan LT; Du CH; Ungaro RC; Walsh S; Grinspan AM
    Dig Dis Sci; 2022 Mar; 67(3):978-988. PubMed ID: 33748913
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fecal Microbiota Transplantation for Severe or Fulminant
    Song YN; Yang DY; Veldhuyzen van Zanten S; Wong K; McArthur E; Song CZ; Ianiro G; Cammarota G; Kelly C; Fischer M; Russell L; Kao D
    J Can Assoc Gastroenterol; 2022 Feb; 5(1):e1-e11. PubMed ID: 35118227
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Factors Related to Outcomes of Fecal Microbiota Transplantation in Patients with
    Yoon H; Shim HI; Seol M; Shin CM; Park YS; Kim N; Lee DH
    Gut Liver; 2021 Jan; 15(1):61-69. PubMed ID: 32839363
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fecal Microbiota Transplantation Is Safe and Effective in Patients With Clostridioides difficile Infection and Cirrhosis.
    Cheng YW; Alhaffar D; Saha S; Khanna S; Bohm M; Phelps E; Ghabril M; Orman E; Sashidhar S; Rogers N; Xu H; Khoruts A; Vaughn B; Kao D; Wong K; Cammarota G; Ianiro G; Dhere T; Kraft CS; Mehta N; Woodworth MH; Allegretti JR; Nativ L; Marcus J; El-Nachef N; Fischer M
    Clin Gastroenterol Hepatol; 2021 Aug; 19(8):1627-1634. PubMed ID: 32645451
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical management of severe, fulminant, and refractory
    Cheng YW; Fischer M
    Expert Rev Anti Infect Ther; 2020 Apr; 18(4):323-333. PubMed ID: 32057278
    [No Abstract]   [Full Text] [Related]  

  • 7. A Multi-Factorial Observational Study on Sequential Fecal Microbiota Transplant in Patients with Medically Refractory
    Monaghan TM; Duggal NA; Rosati E; Griffin R; Hughes J; Roach B; Yang DY; Wang C; Wong K; Saxinger L; Pučić-Baković M; Vučković F; Klicek F; Lauc G; Tighe P; Mullish BH; Blanco JM; McDonald JAK; Marchesi JR; Xue N; Dottorini T; Acharjee A; Franke A; Li Y; Wong GK; Polytarchou C; Yau TO; Christodoulou N; Hatziapostolou M; Wang M; Russell LA; Kao DH
    Cells; 2021 Nov; 10(11):. PubMed ID: 34831456
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fecal microbiota transplantation may reduce the mortality of patients with severe and fulminant Clostridioides difficile infection compared to standard-of-care antibiotics in a community hospital.
    Mironova M; Ehrlich AC; Grinspan A; Protano MA
    J Dig Dis; 2022 Aug; 23(8-9):500-505. PubMed ID: 36183340
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Faecal microbiota transplantation for Clostridioides difficile infection].
    Waldbaum C; López F; Antelo P; Sorda J
    Medicina (B Aires); 2020; 80(6):633-639. PubMed ID: 33254107
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fecal Microbiota Transplantation for Clostridioides difficile in High-Risk Older Adults Is Associated with Early Recurrence.
    Luo Y; Tixier EN; Grinspan AM
    Dig Dis Sci; 2020 Dec; 65(12):3647-3651. PubMed ID: 32078714
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Successful use of early, repeat fecal microbiota transplantation for initial treatment of severe, refractory Clostridioides difficile colitis.
    Cappetto CM
    Am J Health Syst Pharm; 2021 Jul; 78(15):1374-1381. PubMed ID: 33851215
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predictors and Management of Failed Fecal Microbiota Transplantation for Recurrent Clostridioides difficile Infection.
    Tariq R; Saha S; Solanky D; Pardi DS; Khanna S
    J Clin Gastroenterol; 2021 Jul; 55(6):542-547. PubMed ID: 32701563
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Microbial Engraftment and Efficacy of Fecal Microbiota Transplant for Clostridium Difficile in Patients With and Without Inflammatory Bowel Disease.
    Hirten RP; Grinspan A; Fu SC; Luo Y; Suarez-Farinas M; Rowland J; Contijoch EJ; Mogno I; Yang N; Luong T; Labrias PR; Peter I; Cho JH; Sands BE; Colombel JF; Faith JJ; Clemente JC
    Inflamm Bowel Dis; 2019 May; 25(6):969-979. PubMed ID: 30852592
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fecal Microbiota Transplantation for Fulminant Clostridioides Difficile Infection: A Combined Medical and Surgical Case Series.
    Spartz EJ; Estafanos M; Mallick R; Gaertner W; Vakayil V; Jahansouz C; Aggarwal R; Ikramuddin S; Khoruts A; Harmon JV
    Cureus; 2023 Feb; 15(2):e34998. PubMed ID: 36938160
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hospitalized Older Patients with
    Shin JH; Hays RA; Warren CA
    Adv Geriatr Med Res; 2021; 3(2):. PubMed ID: 34263258
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Durability of Response to Fecal Microbiota Transplantation After Exposure to Risk Factors for Recurrence in Patients With Clostridioides difficile Infection.
    Saha S; Mara K; Pardi DS; Khanna S
    Clin Infect Dis; 2021 Oct; 73(7):e1706-e1712. PubMed ID: 32976567
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fecal microbiota transplantation for the treatment of recurrent and severe Clostridium difficile infection in solid organ transplant recipients: A multicenter experience.
    Cheng YW; Phelps E; Ganapini V; Khan N; Ouyang F; Xu H; Khanna S; Tariq R; Friedman-Moraco RJ; Woodworth MH; Dhere T; Kraft CS; Kao D; Smith J; Le L; El-Nachef N; Kaur N; Kowsika S; Ehrlich A; Smith M; Safdar N; Misch EA; Allegretti JR; Flynn A; Kassam Z; Sharfuddin A; Vuppalanchi R; Fischer M
    Am J Transplant; 2019 Feb; 19(2):501-511. PubMed ID: 30085388
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical outcomes after faecal microbiota transplant by retention enema in both immunocompetent and immunocompromised patients with recurrent Clostridioides difficile infections at an academic medical centre.
    Navalkele BD; Polistico J; Sandhu A; Awali R; Krishna A; Chandramohan S; Tillotson G; Chopra T
    J Hosp Infect; 2020 Dec; 106(4):643-648. PubMed ID: 32991940
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fecal Microbiota Transplant for Clostridioides Difficile Infection Is Safe and Efficacious in an Immunocompromised Cohort.
    Suchman K; Luo Y; Grinspan A
    Dig Dis Sci; 2022 Oct; 67(10):4866-4873. PubMed ID: 35000023
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Faecal microbiota transplantation for recurrent Clostridioides difficile infection: an Australian experience - effective, safe, yet room for improvement.
    Chauhan A; Apostolov R; van Langenberg D; Garg M
    Intern Med J; 2021 Jan; 51(1):106-110. PubMed ID: 33572016
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.